Summary
This is a narrative review of nano-technological approaches to improving the delivery and efficacy of phytomedicines. The authors discuss how nanotechnology and polymer-based formulations can overcome traditional barriers to phytomedicine commercialisation—particularly poor solubility and bioavailability—and present evidence for applications across multiple disease categories including metabolic, cardiovascular, and neurological disorders.
Regional applicability
The review is not geographically specific and addresses global challenges in phytomedicine development. The findings on formulation technologies are broadly applicable to United Kingdom pharmaceutical and nutraceutical research and product development, though regulatory pathways for nano-formulations differ between jurisdictions.
Key measures
Solubility, stability, bioavailability, bioactivity of phytochemicals in various nano-formulation systems
Outcomes reported
The paper reviews nano-formulation technologies (solid lipid nanoparticles, liposomes, micelles, phytosomes, etc.) designed to enhance solubility, stability, and bioavailability of phytochemicals. It examines applications of these formulations in treating metabolic, cardiovascular, neurological, viral, inflammatory, and neoplastic disorders.
Topic tags
Dig deeper with Pulse AI.
Ask about this record, its theme or its relevance to UK farming and policy. Pulse AI uses selected catalogue evidence and cites the sources it draws on.